Wuhan Shengke Biology Co., Ltd., registered in national high and new technology industry development zone-Wuhan East Lake High-Tech Development Zone, is a high-tech joint-stock enterprise, which integrates research, development and production of biological products. The registered capital is 21 million; the cumulative investment reaches 75 million; the intent investment reaches 150 million. In accordance with the operation notion of “expansion and recreation; scale development”, our company directs at application research of modern bio-technology and put emphasis on development and production of nucleic acid and its ramification, which has integrated research, production and sales. Or company has cooperated with several famous technology institutes and high schools and employed dozens of senior experts to form a strong research and development team. These experts has been engaged in research of life sciences, nucleic acid medicines and food and nutritious science for decades of years and they are dedicated in tackling key problem of nucleic acid products in our company. They have made several breakthroughs in the field of industrialization production of nucleic acid and nucleotide as well as the development of subsequent products. In succession, our company has launched several high and new technology products including high-quality nucleic acid, nucleotide, nucleotide capsule and oral liquid, cosmetic, vitamin nutritious package and functional drinking, etc; meanwhile, several national patents have been granted. Our company has become an important raw materials base supplying nucleic acid and nucleotide; the products is best-selling in China and it also enjoys a large market share in Europe and America . Nucleotide production project has been approved to be placed in 2001 Torch Plan Projects of Wuhan City and it is funded by Technology Enterprise Technology Creation Fund of Wuhan City without charge. Shengke nucleotide capsule, the outstanding representative of third-generation health products launched in 2002, is one of the latest research achievements, which has successfully solve the problem that exogenous nucleic acid is difficult to be absorbed and transferred by human being’s body and serves as a new breakthrough for nucleic acid material in conditional nutriology as well as clinical nutrition support and application.

        “Employ biological technology to serve human being’s health” is the eternal tenet of our company. We hope that Shengke will give you a healthy and excellent future.